Hepatic ischemia‒reperfusion injury (HIRI) is a common and inevitable complication of hepatic trauma, liver resection, or liver transplantation. It contributes to postoperative organ failure or tissue rejection, eventually affecting patient prognosis and overall survival. The pathological mechanism of HIRI is highly complex and has not yet been fully elucidated. The proposed underlying mechanisms include mitochondrial damage, oxidative stress imbalance, abnormal cell death, immune cell hyperactivation, intracellular inflammatory disorders and other complex events. In addition to serious clinical limitations, available antagonistic drugs and specific treatment regimens are still lacking. Therefore, there is an urgent need to not only clarify the exact etiology of HIRI but also reveal the possible reactions and bottlenecks of existing drugs, helping to reduce morbidity and shorten hospitalizations. We analyzed the possible underlying mechanism of HIRI, discussed various outcomes among different animal models and explored neglected potential therapeutic strategies for HIRI treatment. By thoroughly reviewing and analyzing the literature on HIRI, we gained a comprehensive understanding of the current research status in related fields and identified valuable references for future clinical and scientific investigations.
Citations
Citations to this article as recorded by
Emerging nano/micro drug delivery system for hepatic ischemia-reperfusion injury Xiao Fu, Wanqi Yang, Dongxue Ge, Haozhen Ren Coordination Chemistry Reviews.2026; 549: 217357. CrossRef
Artesunate reduces oxidative stress and inflammation in NAFLD by activating the Nrf2 pathway Qinyu Meng, Mengru Zhong, Jiangrong Zhao, Hong Xu, Wentao Jiang, Chenru Lin, Ghaffar Karishma, Feng Wang, Fang Xu, Yana Li Biochemical Pharmacology.2026; 245: 117643. CrossRef
Ubiquitination of Rhomboid 5 Homolog 2 by Constitutive Photomorphogenic 1 Alleviates Hepatic Ischemia-reperfusion Injury by Regulating the Transforming Growth Factor-β Activating Kinase 1-C-Jun N-terminal Kinase/p38 Signaling Pathway Wendong Li, Tongtong Wu, Hao Li, Zhenyu Guan, Mingjie Ding, Wenzhi Guo Cellular and Molecular Gastroenterology and Hepatology.2026; 20(4): 101695. CrossRef
A Multifunctional Nanoplatform for Treating Hepatic Ischemia–Reperfusion Injury by Modulating the Nrf2 and NF-κB Pathways Ling Shuai, Xiaojun Wang, Xudong Wen, Cong Peng, Tian Dong, Jiejuan Lai, Ling Yao, Shijun Fan, Changchun Zhao, Leida Zhang, Yujun Zhang, Xiang Xiong ACS Applied Materials & Interfaces.2026;[Epub] CrossRef
Identification of key genes related to metabolic cell death in hepatic ischemia-reperfusion injury from transcriptome data and mechanism research using single-cell data HongLi Yu, YingLi Cao, Jiebo Wang, Xianfeng Weng, Weituan Xu Frontiers in Immunology.2026;[Epub] CrossRef
Rutin ameliorates hepatic ischemia-reperfusion injury by targeting CD36 to suppress hepatocyte ferroptosis Zhenlong Liu, Miaomiao Wang, Liangyun Li, Wenmei Zhang, Wenna Meng, Chengjiang Cao, Hehang Song, Xue Fang, Yan Zhu, Ming Yang, Changlin Du, Yuan Zhang, Cheng Huang, Taotao Ma, Jun Li International Immunopharmacology.2026; 172: 116231. CrossRef
The role of gasdermin D-mediated pyroptosis in hepatic ischemia–reperfusion injury and prediction of the therapeutic natural products Xi Chen, Binhui Wang, Wanqian Li, Nan Jin, Guran Lu, Jiabing Wang Biochemical Pharmacology.2026; 247: 117763. CrossRef
A Visible/NIR-II Dual-Channel Fluorescent Probe for Investigating the Roles of NLRP3 Inflammasome and Ferroptosis during Hepatic Ischemia-Reperfusion Injury Jing-Jing Chao, Li-Yuan Chen, Jing Chen, Yu-Xin Ding, Guo-Jiang Mao, Liufang Hu, Juan Ouyang, Chun-Yan Li Analytical Chemistry.2026;[Epub] CrossRef
Leonurine Attenuates Ischemia–Reperfusion Injury Through PI3K/AKT/mTOR Pathway in Mouse Liver Pengru Wang, Xin Hu, Haiyan Pu, Junjie Bai, Lei Sun, Tingting Ma, Yichao Du, Wenguang Fu Phytotherapy Research.2026;[Epub] CrossRef
Crosstalk-free two-channel visualization and precise assessment of autophagy-regulated hepatic ischemia-reperfusion injury by a two-photon fluorescent probe Qing Chang, Qi Wang, Jingyu Zhang, Yan Fang, Jiale Ou, Huimin Zhou, Xianyun Xu, Qi Chen, Yan Feng, Xiangming Meng Sensors and Actuators B: Chemical.2025; 431: 137402. CrossRef
Sinensetin attenuates hepatic ischemia-reperfusion injury through suppressing GRP78/CHOP-mediated endoplasmic reticulum (ER) stress in mice Yihong Yang, Guanghua Xiong, Huangqi Shi, Yulin Peng, Jinghong Liu, Yaxuan Jiang, Min Lu, Hongbo Liu, Yong Liu Frontiers in Pharmacology.2025;[Epub] CrossRef
Biomedical applications of fluorescent probes for detecting ischemia-reperfusion injury in different organs Xinying Jing, Song Han, Yi Yang, Youbo Lai, Weiying Lin Coordination Chemistry Reviews.2025; 534: 216607. CrossRef
Study on the Role of Schisandrin B in Ameliorating Hepatic Ischemia-Reperfusion Injury by Modulating Hepatocyte Autophagy Zhao Fei, Pan Haihang, Chen Xueyang, Shen Miao Iranian Journal of Pharmaceutical Research.2025;[Epub] CrossRef
Mesenchymal stem cell-derived exosomes: an emerging therapeutic strategy for hepatic ischemia-reperfusion injury Bo Zhao, Jiping Wei, Zijian Jiang, Yiming Long, Yan Xu, Botao Jiang Stem Cell Research & Therapy.2025;[Epub] CrossRef
Emerging roles of cuproptosis in liver diseases Qi Yang, Xiaoxuan Liu, Huixin Tang, Yu Chen, Li Bai Digestive and Liver Disease.2025; 57(8): 1541. CrossRef
Identification of PANoptosis related biomarkers to predict hepatic ischemia‒reperfusion injury after liver transplantation Zhihong Chen, Junwei Zhang, Lei Zhang, Yaoge Liu, Ting Zhang, Xinting Sang, Yiyao Xu, Xin Lu Scientific Reports.2025;[Epub] CrossRef
Knowledge graph and emerging trends in oxidative stress research on hepatic ischemia-reperfusion injury: a bibliometric analysis (1995–2024) Simeng Lei, Yangkai Fu, Bo Zhang, Hanwen Yang, Zhili Ji Frontiers in Pharmacology.2025;[Epub] CrossRef
Crocetin, a versatile carotenoid: Novel insights into pharmacological effects, molecular mechanisms, and therapeutic potential Liping Liu, Fan Qiu, Dawei Wu, Tingyu Ding, Wenying Zhang, Yuelei Mao, Ke Xu, Fengying Diao, Huiying Yang, Yunjia Wu, Yuhang Zhang, Lei Zhang, Qin Wu International Immunopharmacology.2025; 162: 115125. CrossRef
Lipid metabolism in liver transplantation: from challenge to chance Yuguan Zhang, Wang Rui, Xinhao Liu, Ya Ye, Sicheng Pu, Kezhen Zong, E Yang, Shanshan Li, Zuotian Huang, Zhongjun Wu Metabolism and Target Organ Damage.2025;[Epub] CrossRef
Perioperative Risk Factors for Early Acute Kidney Injury After Living Donor Liver Transplantation: A Single Transplant Center in Vietnam Ngo Dinh Trung, Do Van Nam, Nguyen Thi Thu, Nguyen Tai Thu, Ho Nam, Hoang Xuan Su Transplantation Proceedings.2025; 57(6): 1063. CrossRef
Feedback Loops Shape Oxidative and Immune Interactions in Hepatic Ischemia–Reperfusion Injury Kenneth J. Dery, Richard Chiu, Aanchal Kasargod, Jerzy W. Kupiec-Weglinski Antioxidants.2025; 14(8): 944. CrossRef
Discovery of a Hepatoprotective Trinor-Sesterterpenoid from the Marine Fungus Talaromyces sp. Against Hepatic Ischemia-Reperfusion Injury Wenxun Lan, Jian Cai, Liyan Yan, Xinyi Wu, Lisha Zhang, Chunmei Chen, Zhongqiu Liu, Xuefeng Zhou, Lan Tang Marine Drugs.2025; 23(8): 329. CrossRef
Elucidating the integrative role and possible molecular mechanisms of
Salvia miltiorrhiza
ingredients and gut microbiota-derived metabolites in alleviating pyroptosis-mediated hepatic ischemia–reperfusion injury throug Rujia Wang, Danhong Yang, Yi Chen, Jiabing Wang Artificial Cells, Nanomedicine, and Biotechnology.2025; 53(1): 420. CrossRef
CKS2 Mediates Hepatocellular Carcinoma Recurrence After Hepatic Ischemia-Reperfusion Injury Related to M2 Macrophages Senzhe Xia, Xueqian Qin, Chenggeng Pan, Dingwei Fan, Daqing Yang Journal of Inflammation Research.2025; Volume 18: 11801. CrossRef
Electroacupuncture Attenuates Hepatic Ischemia‐Reperfusion Injury by Modulating the Esr1/TAK1–JNK/p38 Signaling Pathway in Rats Xiaofang Fan, Wei Guo, Xiaodan Yang, Hao Zhang, Bruno Fink, Lingyu Hu, Xiaoguang Wang, Mirella Giovarelli Mediators of Inflammation.2025;[Epub] CrossRef
FTO-m6A demethylation in cerebral I/R injury: Dual regulation of cell death and neuroinflammation towards therapeutic translation: A review Chenglin Zhu, Xinyu Zhang, Boran Huang, Xinyu Wang, Honggang Wang International Journal of Biological Macromolecules.2025; 328: 147739. CrossRef
Effect of remote ischemic postconditioning on hepatic ischemia–reperfusion injury in patients undergoing laparoscopic hepatectomy: a randomized double-blinded controlled trial Chao Yang, Lijun Yang, Mingwang Zeng, Yunyan Zhu, Chuanwu Zhang, Jing Chen, Yi Wang, Jinji Peng, Li-feng Wang, Maolin Zhong, Haiyu Xie, Weidong Liang Frontiers in Medicine.2025;[Epub] CrossRef
Plasma Proteomic Profiling of Colorectal Cancer: Insights from Minimally Invasive Surgical Cohorts Yang Yan, Yizhao Ma, Pan Xiao, Jingyuan Wang, Sai Xiao, Enqiang Linghu, Pengyue Zhao, Qianqian Chen Journal of Proteome Research.2025; 24(12): 6252. CrossRef
Nicotinic acid protects against hepatic ischemia-reperfusion injury via suppressing mitochondrial damage-induced ferroptosis Qian Zeng, Yina Sun, Mengzhen Lei, Zihan Liu, Xijing Yan, Rong Li, Jun Zheng, Jiandong Zha, Lijun Zhang, Xiaoling Guan, Jia Yao Liver Research.2025; 9(4): 324. CrossRef
Transcriptomic exploration combined with experimental validation: uncovering the potential value of biomarkers related to ammonia-induced cell death in hepatic ischemia–reperfusion injury Runyu Zhuang, Junhao Xiao, Benliang Mao, Yong Yan, Wei Yuan, Fan Wu, Bailin Wang European Journal of Medical Research.2025;[Epub] CrossRef
Discovery of Bergamotanes against Hepatic Ischemia–Reperfusion Injury Based on DeepSAT Technology from Paraconiothyrium sp. H–B Xinye Huang, Xiangli Zhao, Xiaosheng Tan, Yeting Zhang, Zhengyi Shi, Gang Chen, Changxing Qi, Yonghui Zhang Journal of Agricultural and Food Chemistry.2025; 73(49): 31390. CrossRef
Novel Perspectives in Hepatic Ischemia-Reperfusion Injury: The cGAS-STING Pathway Runsheng Chen, Tingfeng Yang, Zhonghao Jiang, Yang Long, Baolin Qian, Wenguang Fu Journal of Inflammation Research.2025; Volume 18: 16427. CrossRef
Protective effects of treprostinil and ischemic preconditioning on hepatic ischemia-reperfusion injury and biomarkers in experimental studies in rats Christina Mouratidou, Efstathios T Pavlidis, Georgios Katsanos, Serafeim-Chrysovalantis Kotoulas, Maria Papaioannou, Georgios Tsoulfas, Emmanouela Apostolopoulou, Georgia D Brellou, Ioannis N Galanis, Theodoros E Pavlidis World Journal of Gastrointestinal Surgery.2025;[Epub] CrossRef
JAG1-Notch signaling drives M1 macrophage polarization in osteoarthritis Shufeng Yang, Li Jiao, Chengcheng Jiang, Guang Li, Fan Sun Archives of Medical Science.2025;[Epub] CrossRef
Artesunate: A potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma Xinyue Liu, Yilin Cai, Yuanhao Zhang, Hetian Zhang, Sisi Tian, Yuxia Gong, Qinmei Song, Xiaotong Chen, Xiao Ma, Yueqiang Wen, Yu Chen, Jinhao Zeng Pharmacological Research.2024; 210: 107526. CrossRef
Liver sinusoidal endothelial cells (LSECs) are liver-specific endothelial cells with the highest permeability than other mammalian endothelial cells, characterized by the presence of fenestrae on their surface, the absence of diaphragms and the lack of basement membrane. Located at the interface between blood and other liver cell types, LSECs mediate the exchange of substances between the blood and the Disse space, playing a crucial role in maintaining substance circulation and homeostasis of multicellular communication. As the initial responders to chronic liver injury, the abnormal LSEC activation not only changes their own physicochemical properties but also interrupts their communication with hepatic stellate cells and hepatocytes, which collectively aggravates the process of liver fibrosis. In this review, we have comprehensively updated the various pathways by which LSECs were involved in the initiation and aggravation of liver fibrosis, including but not limited to cellular phenotypic change, the induction of capillarization, decreased permeability and regulation of intercellular communications. Additionally, the intervention effects and latest regulatory mechanisms of anti-fibrotic drugs involved in each aspect have been summarized and discussed systematically. As we studied deeper into unraveling the intricate role of LSECs in the pathophysiology of liver fibrosis, we unveil a promising horizon that pave the way for enhanced patient outcomes.
Citations
Citations to this article as recorded by
Dark tea ameliorates liver fibrosis via FXR/TGR5-mediated intestinal permeability and liver sinusoidal capillarization Chen-Yu Wang, Sen Liu, Chong Gao, Xu Dai, Li-Hua Lian, Zhen-Yu Cui, Ji-Xing Nan, Yan-Ling Wu Journal of Ethnopharmacology.2026; 354: 120537. CrossRef
Targeting LOXL1-expressing Hepatic Stellate Cell Inhibits Fibrogenesis and Sinusoid Angiogenesis via LOXL1/RUNX1/VEGFA Axis During Progression of Liver Fibrosis Xuzhen Yan, Qi Han, Yiwen Wang, Weiyu Li, Ning Zhang, Xu Fan, Wei Chen, Hong You, Aiting Yang Cellular and Molecular Gastroenterology and Hepatology.2026; 20(2): 101637. CrossRef
Spatial patterning strategies for liver tissue engineering: Biofabrication technologies and applications Haram Nah, Ashlin R. Michell, Kerry M. Rogy, Owen J. Lally, Salman R. Khetani Advanced Drug Delivery Reviews.2026; 228: 115737. CrossRef
Precision Targeting of Hepatic Stellate Cells: Nanotherapeutic Strategies for Liver Fibrosis Regression Xinying Ma, Dawei Chen, Ming Zhao, Haiyang Hu WIREs Nanomedicine and Nanobiotechnology.2026;[Epub] CrossRef
Integrating single-cell RNA sequencing with spatial transcriptomics reveal the fibrosis-related genes in hepatocellular carcinoma Wenying Qiao, Lei Li, Ronghua Jin, Caixia Hu Frontiers in Immunology.2026;[Epub] CrossRef
OGT-enriched Hepatocyte-derived Extracellular Vesicles Promote Capillarization of Liver Sinusoidal Endothelial Cells in Metabolic Dysfunction-associated Steatotic Liver Disease Yanjin Wang, Xulin Zhou, Yu Zhang, Fuji Yang, Yifei Chen, Yanshuang Wu, Lin Zhang, Junfei Tan, Wei Luo, Jing Zhou, Yongmin Yan Cellular and Molecular Gastroenterology and Hepatology.2026; : 101721. CrossRef
LSEC-derived CXCL9 orchestrates immune recruitment and hepatocyte reprogramming in liver fibrosis Jing Li, Qiannan Di, Xiujuan Zhou, Mengling Chang, Wei Chen Acta Biochimica et Biophysica Sinica.2026;[Epub] CrossRef
Kupffer cells: Orchestrators of liver physiology Qin Cai, Yusi Chen, Li Tang Liver Research.2026;[Epub] CrossRef
HBV reprograms the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic implications Xiaodong Shen, Hechen Huang, Jianpeng Sheng, Xiaofeng Tang Clinical and Experimental Medicine.2026;[Epub] CrossRef
Engineered exosomes from umbilical cord mesenchymal stem cells with pPB modification attenuate hepatic fibrosis via hepatic stellate cell targeting Fanghong Wang, Zongbin Sun, Qiuxia Zheng, Xiaofeng Wei, Lu Zhang, Xiaoliang Zhu, Kexiang Zhu, Xiaojing Song, Ping Yue, Fanghui Ding, Lei Zhang, Xun Li Journal of Translational Medicine.2026;[Epub] CrossRef
Recent advances of nanomaterials in imaging liver fibrosis Jin Cui, Shuxuan Zhang, Xueli Xu, Ke Ren, Mengzhen Dong, Zhaokun Nie, Yang Xu, Xiaohui Dai, Peng Xu, Shuo Sun, Xinya Zhao, Xiao Sun BMEMat.2025;[Epub] CrossRef
Immune Checkpoints and the Immunology of Liver Fibrosis Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis Livers.2025; 5(1): 5. CrossRef
Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension Yanqiu Li, Bingbing Zhu, Ke Shi, Yu Lu, Xuanwei Zeng, Yongqi Li, Qun Zhang, Ying Feng, Xianbo Wang Frontiers in Medicine.2025;[Epub] CrossRef
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics Xiao Ma, Tengda Huang, Xiangzheng Chen, Qian Li, Mingheng Liao, Li Fu, Jiwei Huang, Kefei Yuan, Zhen Wang, Yong Zeng Signal Transduction and Targeted Therapy.2025;[Epub] CrossRef
Injury and Fibrosis at the Myoaponeurotic Junction of Pectoralis Major and Supracoracoideus Muscles in Broiler Chickens Takeshi Kawasaki, Tomohito Iwasaki, Takafumi Watanabe, Michi Yamada, Naoyuki Maeda, Yasuhiro Hasegawa, Naoki Takahashi, Ryosuke Kobayashi The Journal of Poultry Science.2025; 62: n/a. CrossRef
Sulfur dioxide-releasing nanomotors improve the therapeutic effect of liver fibrosis by restoring the fenestrae of sinusoids Lin Chen, Zhengwei Chen, Di Shi, Haifeng Ke, Chun Mao, Mimi Wan Journal of Colloid and Interface Science.2025; 692: 137557. CrossRef
Reconstructing the hepatocellular carcinoma microenvironment: the current status and challenges of 3D culture technology Ting Xiong, Kai Wang Discover Oncology.2025;[Epub] CrossRef
Liver Sinusoidal Endothelial Cells in the Regulation of Immune Responses and Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease Munish Puri, Snehal Sonawane International Journal of Molecular Sciences.2025; 26(9): 3988. CrossRef
Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma Young-Min Jee, Jeong-Yoon Lee, Tom Ryu Biomedicines.2025; 13(5): 1260. CrossRef
Mechanism-guided drug development and treatment for liver fibrosis: a clinical perspective Xiangchang Zeng, Deliang Huang, Zhibin Zhu, Qingxian Cai, Yang Yang, Hongzhou Lu, Jun Chen Frontiers in Pharmacology.2025;[Epub] CrossRef
Targeting endoplasmic reticulum proteostasis in liver fibrosis: From signaling mechanisms to therapeutic opportunities Yawei Kong, Zhengyang Chen, Zhentian Nie, Wei Chen Pharmacological Research.2025; 217: 107823. CrossRef
Reactive oxygen species-responsive micelles targeting activated hepatic stellate cells for treating liver fibrosis Xin Yu Liu, He Ying Mao, Jun Sheng Hu, Tong Rui Dou, Ben Chi Liu, Chang Xiu Lin, Cheng-Hua Jin, Ming Guan Piao Journal of Controlled Release.2025; 385: 113997. CrossRef
Liver Sinusoidal Endothelial Cells and Their Regulation of Immunology, Collagenization, and Bioreactivity in Fatty Liver: A Narrative Review Reem J. Abdulmajeed, Consolato M. Sergi International Journal of Molecular Sciences.2025; 26(16): 8006. CrossRef
From cooperation to collapse: systemic failure in liver disease through a sociological lens Junyu Wang, Jingting Lei, Martin C. Harmsen, Han Moshage Exploration of Digestive Diseases.2025;[Epub] CrossRef
Anogeissus leiocarpus (DC.) Guill. & Perr. extract-protected rats against CCl4-induced liver fibrosis Omokolade O. Alejolowo, Olarewaju M. Oluba, Oluyomi S. Adeyemi Journal of Taibah University Medical Sciences.2025; 20(4): 474. CrossRef
Anti-hepatic fibrosis activity and mechanisms of natural polysaccharides: A comprehensive review Xing Yang, Mingyi Shao, Ruixia Zhao, Rui Li, Bingzhao Du, Qian Bi, Yanan Liu, Hongyan Cui International Journal of Biological Macromolecules.2025; 328: 147678. CrossRef
YAP contributes to liver injury through mediating capillarization of liver sinusoidal endothelial cells via GATA6/eNOS signaling Junjun Wang, Zhenyang Shen, Guangwen Chen, Weiming Dai, Zhu Mei, Bo Shen, Yuecheng Guo, Jianxiang Wang, Hanjing Zhangdi, Qingqing Zhang, Jiaqi Gao, Qichao Ge, Hui Zhou, Hui Dong, Lungen Lu, Xiaobo Cai Cellular & Molecular Biology Letters.2025;[Epub] CrossRef
Genomic medicine in hepatology: mechanisms and liver treatment strategies D. S. Kozlov, S. Rodimova, P. Filatov, A. Mozherov, P. S. Timashev, M. V. Zyuzin, D. S. Kuznetsova Molecular Medicine.2025;[Epub] CrossRef
Piezo-mediated mechanically activated currents in organ fibrosis: Novel mechanisms and therapeutic strategies Ling Dong, Li-Chan Lin, Sui Mao, Zhen-Yu Liu, Peng Liu, Rui Li, Hui Tao, Ye Zhang Life Sciences.2025; 382: 124050. CrossRef
Retinal Sensitivity Loss and Beyond in KCNV2-Related Retinopathy: The First Genetically Confirmed Case in Türkiye Özlem Ural Fatihoğlu, Ayşe Bozkurt Oflaz, Özlem Özkan, Hande Taylan Şekeroğlu, Ali Osman Saatçi Turkish Journal of Ophthalmology.2025; 55(6): 352. CrossRef
Hepatic Fibrosis and Liver Cancer Aina Anton, Scott L. Friedman, Bruno Cogliati Seminars in Liver Disease.2025;[Epub] CrossRef
Transcriptome Analyses of Liver Sinusoidal Endothelial Cells Reveal a Consistent List of Candidate Genes Associated with Endothelial Dysfunction and the Fibrosis Progression Penghui Li, Wenjie Xie, Hongjin Wei, Fan Yang, Yan Chen, Yinxiong Li Current Issues in Molecular Biology.2024; 46(8): 7997. CrossRef
Correspondence to editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis” Jiaorong Qu, Le Wang, Xiaojiaoyang Li Clinical and Molecular Hepatology.2024; 30(4): 1002. CrossRef
Unlocking the role of liver sinusoidal endothelial cells: Key players in liver fibrosis: Editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis” Yasuko Iwakiri Clinical and Molecular Hepatology.2024; 30(4): 673. CrossRef
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease Hui Gao, Yanchao Jiang, Ge Zeng, Nazmul Huda, Themis Thoudam, Zhihong Yang, Suthat Liangpunsakul, Jing Ma eGastroenterology.2024; 2(4): e100104. CrossRef
Exploring the Role of Peroxisome Proliferator-Activated Receptors and Endothelial Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease Ana Paula Madariaga Traconis, Misael Uribe-Esquivel, Varenka Julieta Barbero Becerra Cells.2024; 13(24): 2055. CrossRef
Si-Wu-Tang improves liver fibrosis by restoring liver sinusoidal endothelial cell functionality and reducing communication with hepatic stellate cells Le Wang, Jiaorong Qu, Jianan Li, Xiaoyong Xue, Lingling Qin, Yufei Li, Yuanfeng Dou, Xiaohong Mu, Xiaojiaoyang Li Chinese Medicine.2024;[Epub] CrossRef
First
Prev
